Right Place at the Right Time
Right Place at the Right Time Sometimes, life has a strange way of preparing us…
News
Statement of Lymphoma Research Foundation on Access to Treatment
Policymakers in Washington, DC, and state capitols are considering measures to address the cost of health care, including prescription drugs, and to address insurance adequacy issues. As debate on these initiatives intensifies, we urge that policymakers consider the needs of people with lymphoma and lymphoma survivors.
Statement Of Lymphoma Research On Access To Quality Cancer Care In Response To Dobbs V. Jackson Women’s Health Organization
Statement of Lymphoma Research on Access to Quality Cancer Care In Response to Dobbs V.…
What Lymphoma Patients Need to Know About Current Treatments for COVID-19
As of mid-2022, there are a number of treatments for COVID-19 that have been either approved by the FDA or have been authorized for emergency use (EUA).
Lymphoma Research Foundation Names Sarah Quinlan Chief Program Officer
Lymphoma Research Foundation Names Sarah Quinlan Chief Program Officer The Lymphoma Research Foundation (LRF) –…
U.S. Food and Drug Administration Approves Lisocabtagene Maraleucel (BREYANZI) for Large B-Cell Lymphoma
The U.S. Food and Drug Administration Approves Lisocabtagene Maraleucel (Breyanzi) for Large B-Cell Lymphoma On…
U.S. Food and Drug Administration Approves CAR T Cell Therapy for Follicular Lymphoma
FDA announced it has approved the use of tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy.
Meet the 2022 Career Development Award, Postdoctoral Fellowship, and Follicular Lymphoma Priority Research Grantees
The Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma clinical and laboratory/translational research.
Advocating for Answers
After 20 years of living with lymphoma, Lois Rosenblum knows firsthand the importance of a strong support system and advocating
for your health. Following an initial diagnosis of follicular lymphoma in 2002 and several disease transformations since then, she’s passionate about supporting the work that the Lymphoma Research Foundation (LRF) does to power cutting-edge research to treat and defeat lymphoma.
Where Are They Now? Carla Casulo, MD
Dr. Carla Casulo is a medical oncologist at the University of Rochester Medical Center.
Stay informed with news, alerts and other resources.
